Ondine Biomedical, Inc. (OBIMF)
0.25
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Ondine Biomedical Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 01, 2026 | 4.154M |
| May 29, 2026 | 4.154M |
| May 28, 2026 | 3.381M |
| May 27, 2026 | 3.381M |
| May 26, 2026 | 3.381M |
| May 22, 2026 | 3.381M |
| May 21, 2026 | 3.381M |
| May 20, 2026 | 3.381M |
| May 19, 2026 | 3.381M |
| May 18, 2026 | 3.381M |
| May 15, 2026 | 3.381M |
| May 14, 2026 | 3.381M |
| May 13, 2026 | 3.381M |
| May 12, 2026 | 3.381M |
| May 11, 2026 | 3.381M |
| May 08, 2026 | 3.381M |
| May 07, 2026 | 3.381M |
| May 06, 2026 | 3.381M |
| May 05, 2026 | 3.381M |
| May 04, 2026 | 3.381M |
| May 01, 2026 | 3.381M |
| April 30, 2026 | 3.381M |
| April 29, 2026 | 3.381M |
| April 28, 2026 | 3.381M |
| April 27, 2026 | 3.381M |
| Date | Value |
|---|---|
| April 24, 2026 | 3.381M |
| April 23, 2026 | 3.381M |
| April 22, 2026 | 3.381M |
| April 21, 2026 | 3.381M |
| April 20, 2026 | 3.381M |
| April 17, 2026 | 3.381M |
| April 16, 2026 | 3.381M |
| April 15, 2026 | 3.381M |
| April 14, 2026 | 3.381M |
| April 13, 2026 | 3.381M |
| April 10, 2026 | 3.381M |
| April 09, 2026 | 3.381M |
| April 08, 2026 | 3.381M |
| April 07, 2026 | 3.381M |
| April 06, 2026 | 3.381M |
| April 02, 2026 | 3.381M |
| April 01, 2026 | 3.381M |
| March 31, 2026 | 3.381M |
| March 30, 2026 | 3.381M |
| March 27, 2026 | 3.381M |
| March 26, 2026 | 3.381M |
| March 25, 2026 | 3.381M |
| March 24, 2026 | 3.381M |
| March 23, 2026 | 3.381M |
| March 20, 2026 | 3.381M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Edesa Biotech, Inc. | 44.67M |
| Co-Diagnostics, Inc. | 11.38M |
| ProMIS Neurosciences, Inc. | 27.62M |
| Numinus Wellness, Inc. | -- |
| Alpha Tau Medical Ltd. | 767.34M |
Enterprise Value Related Metrics
| Earnings Yield | -18.20% |
| Normalized Earnings Yield | -18.20 |